Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium after Doxorubicin-based Chemotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 38, Issue 4, 2015, Pages 377-381

  Lunning, Matthew A ^a   Kutty, Shelby ^b   Rome, Eric T ^a   Li, Ling ^b   Padiyath, Asif ^b   Loberiza, Fausto ^a   Bociek, Robert Gregory ^a   Bierman, Philip J ^a   Vose, Julie M ^a   Armitage, James O ^a   Porter, Thomas R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

anthracycline; cardiac magnetic resonance imaging; cardiomyopathy; doxorubicin; lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GADOLINIUM; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; MONOCLONAL ANTIBODY; R-CHOP PROTOCOL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; TREATMENT DURATION; CARDIOMYOPATHIES; CARDIOTOXICITY; CASE CONTROL STUDY; CHEMICALLY INDUCED; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARDIOMYOPATHIES; CARDIOTOXICITY; CASE-CONTROL STUDIES; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDNISONE; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VINCRISTINE;

EID: 84938602882     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31829e19be     Document Type: Article

References (24)

1. Tan C, Takasaka H, Yu KP, et al. Daunorubicin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. 1967;20:333-353
2. Arcamone F, Cassenilli G, Fantini G, et al. Adriamycin, 14-hydroxydaunorubicin, a new anti-tumor antibiotic from S. peucetius var. caesius. Biotechnical Bioeng. 1969;11:1101-1110
3. DiMarco A, Gaetani M, Scarpinato B. Adriamycin (NSC-123, 127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969;53:33-37
4. Lefrak EA, Pitha J, Rosenheim S, et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973;32:302-314
5. Von Hoff D, Layard M, Basa P, et al. Risk factors for doxorubicininduced congestive heart failure. Ann Intern Med. 1979;91:710-717
6. Von Hoff DD, Rozencweig M, Layard M, et al. Daunomycininduced cardiotoxicity in children and adults: a review of 110 cases. Am J Med. 1977;62:200-208
7. Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol. 2005;184:1420-1426
8. Gottlieb I, Macedo R, Bluemke DA, et al. Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current application and future perspectives. Heart Fail Rev. 2006; 11:313-323
9. Ryberg M, Nielsen D, Skovsqaard T, et al. Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer. J Clin Oncol. 1998;16:3502-3508
10. Haq MM, Legha SS, Choksi J, et al. Doxorubicin-induced congestive heart failure in adults. Cancer. 1985;56:1361-1365
11. Anderlini P, Benjamin RS, Wong FC, et al. Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia. J Clin Oncol. 1995;13:2827-2834
12. Aviles A, Arevila A, Diaz Maqueo JC, et al. Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. Leuk Lymphoma. 1993;11:275-279
13. Tjeerdsma G, Meinardi MT, van der Graaf WT, et al. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables. Heart. 1999;81:419-423
14. Limat S, Demesmay K, Voillat L, et al. Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma. Ann Oncol. 2003;14:277-281
15. Eidem BW. Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough. J Am Soc Echocardiogram. 2008;21:1290-1292
16. Oberholzer K, Kunz RP, Dittrich M, et al. Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer. Rofo. 2004;176:1245-1250
17. Petri S, Esko V, Esa J, et al. A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy. Nuc Med Commun. 2012;33: 51-59
18. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542
19. Maret E, Todt T, Brudin L, et al. Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovascular Ultrasound. 2009;7:53
20. Poterucha J, Kutty S, Lindquist R, et al. Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012;25:733-740
21. Hor KN, Gottliebson WM, Carson C, et al. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging. 2010;3:144-151
22. Cheung YF, Hong WJ, Chan GC, et al. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy. Heart. 2010;96:1137-1141
23. Kutty S, Rangamani S, Venkataraman J, et al. Reduced global longitudinal and radial strain with normal left ventricular ejection fraction late after effective repair of aortic coarctation: a CMR feature tracking study. Int J Cardiovasc Imaging. 2013;29: 141-150
24. Lightfoot JC, D'Agostino RB, Hamilton CA, et al. Novel approach to early detection of doxorubicin cardiotoxicity by gadoliniumenhanced cardiovascular magnetic resonance imaging in an experimental model. Circ Cardiovasc Imaging. 2010;3:550-558